MedTrace Logo

A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

NCT07062237 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2026-04-21

No results posted yet for this study

Summary

This research is being done to determine if producing sperm after an ultrashort period of abstinence (1 hour of abstinence) will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothesize that a shorter period of abstinence is effective at improving rates of normal chromosomes among embryos.

Conditions

Interventions

OTHER

Ultrashort abstinence

Ultrashort abstinence: producing a sperm sample after 1 hour of abstinence.

OTHER

Standard abstinence

Standard abstinence: producing a sperm sample after 2-5 days of abstinence.

Sponsors & Collaborators

  • The Center for Advanced Reproductive Services, P.C.

    collaborator OTHER

  • UConn Health

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-27
Primary Completion
2026-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07062237 on ClinicalTrials.gov